Clinical trial
CorMatrix ECM Study: To Identify Inflammatory Markers Following CABG With/Without CorMatrix's Extra Cellular Matrix (ECM)
NCT01535807 is registered in ClinicalTrials.gov with Inova Health Care Services as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CorMatrix ECM Study: To Identify Inflammatory Markers Following CABG With/Without CorMatrix's Extra Cellular Matrix (ECM)
- Lead sponsor
- Inova Health Care Services
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- January 31, 2012
- Completion date
- June 30, 2016
- Enrollment
- 44 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.